Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help
Skip to main content

Access brought to you by: LOCKSS

Login

MD Conference Express
Advanced Search

Main menu

  • HOME
  • BROWSE BY CONFERENCE
  • BROWSE BY DISCIPLINE
    • -- All Disciplines --
    • Anesthesiology
    • Cardiology & Cardiovascular Medicine
    • Dentistry
    • Dermatology
    • Endocrinology, Diabetes & Metabolism
    • Emergency Medicine & Critical Care
    • Hematology
    • Hepatology
    • Infectious Diseases
    • Nephrology
    • Neurology
    • Nutrition
    • Obstetrics & Gynecology
    • Oncology
    • Ophthalmology
    • Orthopaedics & Sports Medicine
    • Psychiatry & Psychology
    • Pulmonary & Respiratory Medicine
    • Radiology
    • Rheumatology
    • Veterinary Medicine
  • ABOUT
    • About Us
    • International Medical Advisory Board
    • Reprints
    • Librarian resources
    • Contact us
    • Help


 

Featured Articles

  • New Technologies and Big Data Provide Hope for the Future in Patient Care
  • Genomics/Omics for Cardiovascular Disease Gene Discovery and Translation

Clinical Trial Highlights

  • TL-PAS Shows Reduction of Ischemic Events with Long-Term Prasugrel
  • ITALIC/ITALICplus: 12-Month Data Suggest 6 Months of DAPT is Noninferior to 24 Months of DAPT
  • ISAR-SAFE: No Difference in 6-Month vs 12-Month DAPT after DES
  • DAPT Study: Benefits Seen with Prolonged DAPT after DES Treatment
  • Aspirin Fails to Reduce CVD in Elderly Japanese
  • Alirocumab Has Greater Reduction of LDL-C Than Ezetimibe in Patients with Statin Intolerance
  • Ezetimibe Plus Statin Reduces CV Events after ACS
  • Losartan Lacks Benefit in Inherited HCM
  • CABG Plus Valve Repair Provides No Benefit in MR over CABG Alone
  • BASKET-PROVE II: BP-DES Noninferior to DP-DES
  • SYNERGY Everolimus-Eluting Stent Noninferior to PROMUS Element Plus: Results from EVOLVE II Randomized Clinical Trial
  • AVOID: Oxygen Use Damaging in STEMI
  • PARADIGM-HF: Disease Progression Slowed with Novel Drug
  • PreSERVE-AMI: CD34+ Cells Improve Cardiac Function, Reduce Events after STEMI
  • ENGAGE AF-TIMI 48: Edoxaban Safe and Effective in Elderly Patients with AF

Selected Updates

  • Perspectives on the 2013 ACC/AHA Guidelines to Reduce CV Risk
  • Management of AF Based on New Science and New Guidelines
  • Diabetes and HF: Nexus of 2 Epidemics
Back to top
PreviousNext

Other Products from SAGE / CQ Press

  • SAGE Journals
  • SAGE Knowledge
  • SAGE Research Methods
  • Help
Copyright © by SAGE Publications
Online ISSN: 1559-8977